The global renal biomarkers market is estimated to be valued at US$ 1,476.2 million in 2023 and is expected to exhibit a CAGR of 8.2% during the forecast period (2023-2030).
A biomarker is a measurable indicator of a healthy biological process in an organism. Renal biomarkers play a crucial role in the diagnosis of acute and chronic kidney damage and the diagnosis of a wide range of kidney illnesses. The perfect renal biomarker would diagnose kidney problems early on. Renal biomarkers help diagnose or identify the patients at risk of developing kidney diseases, by measuring their blood or urine levels. They are commonly released in acute or chronic kidney injuries, which are characterized by the rapid or gradual loss of kidney function resulting into serous clinical implications.
Premium Sample of This Strategic Report @ https://www.coherentmarketinsights.com/insight/request-sample/3551
Our Sample Report Includes:
📝 Industry Overview and Segmentation.
📝 Brief Introduction to the research report.
📝 Table of Contents (Scope covered as a part of the study).
📝 Competitive Outlook of Industry.
📝 Research framework (Structure of the report).
📝 Research methodology adopted by Coherent Market Insights.
Global Renal Biomarkers Market: Competitive Landscape
Some of the most important companies in the world market for renal biomarkers are: Beckman Coulter, Inc., (Danaher Corporation), Thermo Fisher Scientific Inc., Abbott Laboratories, BIOPORTO A/S, Astute Medical, Inc., Randox Laboratories Ltd., and SphingoTec GmbH.
- Global Renal Biomarkers Market, By Biomarker Type:
- Functional Biomarker
- Up-Regulated Proteins
- Global Renal Biomarkers Market, By Technique:
- Enzyme Linked Immunosorbent Assay
- Particle-enhanced Turbidimetric Immunoassay
- Calorimetric Assay
- Chemiluminescent Enzyme Immunoassay
- Liquid Chromatography-Mass Spectrometry
- Global Renal Biomarkers Market, By End User:
- Diagnostic Labs
- Outpatient Clinics
- Research Centers
Global Renal Biomarkers Market: Drivers
The worldwide market for renal biomarkers is anticipated to expand in the predicted period due to the rising incidence of chronic kidney disorders. Data from the European Renal Association and the European Dialysis and Transplant Association in 2018 indicate that more than 850 million individuals around the world suffer from kidney disease.
The market is predicted to expand because of the rising prevalence of pediatric chronic renal disease. For instance, in a study titled “Risk Factors and Rate of Progression of CKD in Children,” published in Kidney International Reports in June 2019, 38% of children saw that within two years of follow-up, chronic renal disease deteriorates further.
In 2018, North America accounted for 32.5% of the worldwide renal biomarkers market’s value, making it the region’s most lucrative.
Global Renal Biomarkers Market: Restraints
The worldwide market forl renal biomarkers is anticipated to be slowed by biomarkers’ low sensitivity and specificity. Certain biomarkers for the kidneys, like L-18, are extremely specific but not particularly sensitive, while others, like osteopontin, are highly sensitive but not specific.
Market expansion is also anticipated to be hampered by the widespread use of flawed gold standards. Despite its low sensitivity and specificity, serum creatinine is considered the gold standard. Increases in serum creatinine can have many different reasons, including renal damage, hemodynamic (obstructive uropathy) mediated alterations, and others. In addition, creatinine in the blood is useless in gauging renal health.
Quick Buy This Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/3551
Global Renal Biomarkers Market: Opportunities
Market participants may prioritize academic partnerships that help discover new biomarkers for use in medication development.
Moreover, research and development in renal biomarkers is anticipated to contribute to market expansion. Micro albuminuria is a urine-based biomarker for early prediction of diabetic kidney failure, as was published in February 2020 by researchers at NLC India Ltd, the National Institute of Mental Health and Neurosciences, and the Madras Diabetes Research Foundation (MDRF), Chennai, India.
The worldwide renal biomarkers market’s functional biomarkers sector was worth US$ 543.61 million in 2018, and it is projected to be worth US$ 1,057.3 million by 2027, a CAGR of 7.6%.
Market Trends/Key Takeaways
Renal biomarkers in cats are the current focus of the industry. Antech SDMA (symmetric dimethylarginine) is a feline renal biomarker released in February 2020 by Antech Diagnostics, a branch of Mars Petcare, for the early diagnosis, staging, and monitoring of chronic kidney disease.
Market leaders are also devoting considerable resources to research and development of renal biomarkers. The kidney function biomarker penKid, developed by SphingoTec GmbH, was the subject of fresh study results that were published in BMC Emergency Medicine in December 2019.
Global Renal Biomarkers Market: Key Developments
Market leaders are concentrating on introducing innovative new items to consumers. SphingoTec GmbH, for instance, introduced their CE-IVD designated point-of-care test for the renal biomarker Proenkephalin, IB10 sphingotest penKid, in January 2020.
Many players in the market are also pressing for the widespread adoption of innovative biomarkers. The NGAL Test is a biomarker test that can be used to assess the risk of acute kidney injury in children, and in November 2019, BioPorto A/S confirmed that it would submit additional information to the U.S. Food and Drug Administration (FDA) in assistance of its pediatric 510(k) application for clearance of the test.
Reason to Buy this Report:
■ Analysis of the impact of technological advancements on the market and the emerging trends shaping the industry in the coming years.
■ Examination of the regulatory and policy changes affecting the market and the implications of these changes for market participants.
■ Overview of the competitive landscape in the Renal Biomarkers market, including profiles of the key players, their market share, and strategies for growth.
■ Identification of the major challenges facing the market, such as supply chain disruptions, environmental concerns, and changing consumer preferences, and analysis of how these challenges will affect market growth.
■ Evaluation of the potential of new products and applications in the market, and analysis of the investment opportunities for market participants.
Ask Here for Customization Report @ https://www.coherentmarketinsights.com/insight/request-customization/3551
Table of Contents with Major Points:
- Key Findings
- Definitions and Assumptions
- Definition of Renal Biomarkers Market
- Market Dynamics
- Trends and Developments
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Renal Biomarkers Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
- Data Sources
Why Choose Coherent Market Insights
➥ Serving domestic and international clients 24/7
➥ Prompt and efficient customer service
➥ Data collected from reliable primary and secondary sources
➥ Highly trained and experienced team of research analysts
➥ Seamless delivery of tailor-made market research reports
Related Market Intelligence Reports:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Senior Client Partner – Business Development
Coherent Market Insights